The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Molecular residual disease (MRD) detection using bespoke circulating tumor DNA (ctDNA) assays in localized soft tissue sarcoma (STS).
 
Abdulazeez Salawu
No Relationships to Disclose
 
Elizabeth Demicco
Consulting or Advisory Role - Bayer
Patents, Royalties, Other Intellectual Property - Authorship Royalties, from UpToDate (Wolters Kluwer), Chapter: "Solitary fibrous tumors"
 
Peter W. M. Chung
Honoraria - Abbvie; AstraZeneca; Boston Scientific
Consulting or Advisory Role - Tersera; Tolmar; Verity Pharmaceuticals
Research Funding - Abbvie
 
Jordan Feeney
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Erik Spickard
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Richa Rathore
Employment - Natera
Stock and Other Ownership Interests - Natera
 
Jasmine Lee
No Relationships to Disclose
 
Philip Wong
Research Funding - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Eoghan Ruadh Malone
No Relationships to Disclose
 
Charles Catton
Honoraria - Abbvie; Bayer; Knight Therapeutics; Tersera
 
Limore Arones
No Relationships to Disclose
 
Madeline J. Phillips
No Relationships to Disclose
 
Peter Charles Ferguson
No Relationships to Disclose
 
Jay Wunder
No Relationships to Disclose
 
Tony Tin
Employment - Natera
Stock and Other Ownership Interests - Natera
Travel, Accommodations, Expenses - Natera
 
Himanshu Sethi
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Natera
Patents, Royalties, Other Intellectual Property - Patents
Travel, Accommodations, Expenses - Natera
 
Minetta C. Liu
Employment - Natera
Stock and Other Ownership Interests - Natera
Research Funding - Eisai (Inst); Exact Sciences (Inst); Genomic Health (Inst); GRAIL (Inst); Menarini Silicon Biosystems (Inst); Merck (Inst); Novartis (Inst); Roche/Genentech (Inst); Seagen (Inst); Tesaro (Inst)
Travel, Accommodations, Expenses - AstraZeneca (Inst); Genomic Health; GRAIL; Menarini Silicon Biosystems; Merck; Natera; Pfizer
 
David Benjamin Shultz
No Relationships to Disclose
 
Albiruni Ryan Abdul Razak
Consulting or Advisory Role - Adaptimmune; Bayer; GlaxoSmithKline; Inhibrx; Medison
Research Funding - 23 and Me; Abbvie; Adaptimmune; Amgen; Blueprint Medicines; Boehringer Ingelheim; Bristol-Myers Squibb; Daiichi Sankyo; Deciphera; Frontier Therapeutics; GlaxoSmithKline; Iterion Therapeutics; Karyopharm Therapeutics; MedImmune; Merck; Neoleukin Therapeutics; Pfizer; Rain Therapeutics; Roche/Genentech; Symphogen
Expert Testimony - Medison